A monoclonal antibody recognising human CD29/integrin beta 1, used to study integrin activation, cell adhesion and cell–matrix interactions.
| Inventor | Institute |
|---|---|
| Martin Humphries | University of Manchester |
| SKU: | 152482 |
|---|---|
| Product description: | Anti-CD29 [12G10] is a mouse monoclonal antibody that recognises human CD29, also known as integrin beta 1. It is used to study integrin activation, cell adhesion and cell–matrix interactions, supporting research into integrin-mediated signalling, immune response, tissue repair and tumour cell adhesion. Clone 12G10 recognises a ligand-induced binding site epitope on the beta 1 integrin subunit. Reported applications include ELISA, FACS, immunohistochemistry, immunofluorescence, immunoprecipitation and western blot. |
| Alternate name: | Integrin Subunit Beta 1; Glycoprotein Iia; MSK12; GPIIA; FNRB; MDF2; Very Late Activation Protein; Beta Polypeptide; Fibronectin Receptor Subunit Beta; Integrin VLA-4 Beta Subunit; CD29 Antigen; VLA-BETA; CD29; VLAB |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Purified human ?1 integrin preparation from HT1080 fibrosarcoma cell extract. |
| Myeloma used: | P3X63Ag8.653 |
| Cat. #: | 152482 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer; Cell biology; Cell signaling and signal transduction; Genetics; Immunology |
| Application: | ELISA ; FACS ; IHC ; IF ; IP ; WB |
| Target: | CD29 (Integrin b1 chain) |
| Reactivity: | Human |
| Clone: | 12G10 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | CD29 is a member of the family of integrins, membrane receptors involved in cell adhesion and recognition in a variety of processes including embryogenesis, hemostasis, tissue repair, immune response and metastatic diffusion of tumor cells. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Chen et al. 2009. PLoS One. 4(8):e6565. PMID: 19668337. Yamamoto et al. 2009. Endocrinology. 150(2):990-9. PMID: 18845630. Yamamoto et al. 2007. Br J Cancer. 97(11):1538-44. PMID: 17971775. Cavallo-Medved et al. 2005. J Cell Sci. 118(Pt 7):1493-503. PMID: 15769846. Avizienyte et al. 2002. Nat Cell Biol. 4(8):632-8. PMID: 12134161. Iba et al. 2000. J Cell Biol. 149(5):1143-56. PMID: 10831617. Mould et al. 1998. Biochem J. 331 ( Pt 3):821-8. PMID: 9560310. Mould et al. 1995. Biochem Soc Trans. 23(3):395S. PMID: 8566283. Regulation of integrin alpha 5 beta 1 function by anti-integrin antibodies and divalent cations. Mould et al. 1995. FEBS Lett. 363(1-2):118-22. PMID: 7537221. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.